ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	12 December 2020
Main ID:	NCT03474484
Date of registration:	15/03/2018
Prospective Registration:	Yes
Primary sponsor:	St. Olavs Hospital
Public title:	Calprotectin I Serum as a Diagnostic Marker
Scientific title:	Calprotectin I in Serum as a Diagnostic Marker of Pneumonia in Patients Hospitalised With Acute COPD Exacerbation
Date of first enrolment:	April 3, 2018
Target sample size:	113
Recruitment status:	Completed
URL:	https://clinicaltrials.gov/show/NCT03474484
Study type:	Observational
Study design:
Phase:

Countries of recruitment
Norway

Contacts

Name:	Anne h. Henriksen, md phd
Address:
Telephone:
Email:
Affiliation:	St Olavs Hospital HF

Key inclusion & exclusion criteria

Inclusion Criteria:

- clinically confirmed acute exacerbation of chronic obstructive pulmonary disorder
(AECOPD)

- COPD diagnosis previously confirmed by spirometry according to the GOLD criteria.

Exclusion Criteria:

- known malignant disease

- bronchiectasis

- chronic bacterial colonisation of the airways

- treatment with an immunosuppressive drug or long-term treatment with antibiotics.

- not examined with a chest X-ray at admission

Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Pulmonary Disease, Chronic Obstructive

Intervention(s)

Primary Outcome(s)

Calprotectin concentration in serum [Time Frame: Change in serum concentration from baseline to 48 hours]

Secondary Outcome(s)

Secondary ID(s)

20171496/REK midt

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Norwegian University of Science and Technology

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.